Net Cash Provided by (Used in) Operating Activities |
-528K |
USD |
+5.38% |
Q4 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
200K |
USD |
|
Q4 2023 |
Q1 2025 |
Common Stock, Shares Authorized |
300M |
shares |
0% |
Q1 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
53.2M |
shares |
0% |
Q1 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-528K |
USD |
-47.5% |
Q4 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
3.8M |
USD |
+217% |
Q1 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
12.6M |
USD |
+5.02% |
Q3 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
12.6M |
USD |
+5.01% |
Q3 2024 |
FY 2024 |
Depreciation |
1.65K |
USD |
-54.2% |
Q4 2024 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-3.31M |
USD |
-32.8% |
Q1 2025 |
Q2 2025 |
Property, Plant and Equipment, Gross |
150K |
USD |
-89.6% |
Q1 2025 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
8.95M |
USD |
+5.73% |
Q3 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2025 |
Q2 2025 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q1 2025 |
Q2 2025 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2024 |
FY 2024 |
Additional Paid in Capital |
83.6M |
USD |
+0.52% |
Q1 2025 |
Q2 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2025 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
829 |
USD |
-40.5% |
Q3 2024 |
FY 2024 |
Share-based Payment Arrangement, Expense |
51.6K |
USD |
+122% |
Q4 2024 |
Q1 2025 |
Preferred Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q1 2025 |
Q2 2025 |